Federal Contractor Profile
Siga Technologies, INC.
$724M obligated·6 awards·2 agencies·3 NAICS
Federal Contracts
Showing award actions 1–30 of 30 funded award actions, most recent first.
- Contracts with positive obligations
- 6
- Funded award actions shown
- 30
- Obligations shown
- $724M
- Awarding agencies
- 2
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of August 24, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Aug 7, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $2.1M |
| Jun 3, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $13M |
| Apr 7, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $14M |
| Mar 24, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $26M |
| Aug 2, 2024 | Department of DefenseW6QK ACC-APG | W911SR24C0030 | 325412 | PROCUREMENT OF 23,030 TPOXX ORAL COURSES AND 50 TPOXX IV COURSES. TO MAINTAIN NATIONAL STOCKPILE. | $9.0M |
| Jul 16, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $113M |
| Feb 15, 2024 | Department of DefenseW6QK ACC-APG | W911SR22C0051 | 325412 | PROCURE UP TO 23000 TPOXX COURSES FOR SMALL POX TREATMENT. | $1.1M |
| Jul 27, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $138M |
| Mar 30, 2023 | Department of DefenseW6QK ACC-APG | W911SR22C0051 | 325412 | PROCURE UP TO 23000 TPOXX COURSES FOR SMALL POX TREATMENT. | $5.5M |
| Sep 29, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201100001C | 541711 | DRUGS AND BIOLOGICALS | $2.6M |
| Sep 28, 2022 | Department of DefenseW6QK ACC-APG | W911SR22C0051 | 325412 | PROCURE UP TO 23000 TPOXX COURSES FOR SMALL POX TREATMENT. | $5.2M |
| Aug 25, 2022 | Department of DefenseW6QK ACC-APG | W911SR22C0032 | 325412 | PROCURE COURSES OF FDA APPROVED TPOXX DRUG/THERAPEUTIC | $3.8M |
| Aug 4, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $29M |
| May 12, 2022 | Department of DefenseW6QK ACC-APG | W911SR22C0032 | 325412 | PROCURE COURSES OF FDA APPROVED TPOXX DRUG/THERAPEUTIC | $3.6M |
| Feb 3, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSN272200800041C | 541711 | CONTRACT AWARD HHSN272200800041C UNDER BAA NIH-NIAID-DMID-08-20 | $220K |
| Sep 7, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $113M |
| Apr 26, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $15K |
| Jul 2, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSN272200800041C | 541711 | CONTRACT AWARD HHSN272200800041C UNDER BAA NIH-NIAID-DMID-08-20 | $2K |
| Apr 23, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $101M |
| Sep 5, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $2.4M |
| May 22, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSN272200800041C | 541711 | CONTRACT AWARD HHSN272200800041C UNDER BAA NIH-NIAID-DMID-08-20 | $2.1M |
| May 20, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $11M |
| Feb 21, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $12M |
| Sep 10, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118C00019 | 541714 | PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF | $52M |
| Jul 30, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201100001C | 541711 | DRUGS AND BIOLOGICALS | $50M |
| Feb 8, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSN272200800041C | 541711 | CONTRACT AWARD HHSN272200800041C UNDER BAA NIH-NIAID-DMID-08-20 | $10M |
| Sep 21, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201100001C | 541711 | DRUGS AND BIOLOGICALS | $2.0M |
| Jul 15, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSN272200800041C | 541711 | CONTRACT AWARD HHSN272200800041C UNDER BAA NIH-NIAID-DMID-08-20 | $2.5M |
| Apr 22, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201100001C | 541711 | DRUGS AND BIOLOGICALS | $4.8M |
| Dec 10, 2015 | Department of Health and Human ServicesOFF ASST SEC ADM AND MGMT | HHSO100201100001C | 541711 | DRUGS AND BIOLOGICALS | $2.1M |
Get Alerted Before Siga Technologies, INC.'s Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free